A solution for colic babies and their parents’ wellbeing
Infant Colic (IC) affects up to 20% of babies from birth and up to four months of age. Colic babies cry inconsolably for hours, which causes significant suffering and stress for them and their families.
SURI BioTech, an ETH start-up, developed BactoKind, a consortium of bacterial strains that impacts the metabolism of the gut microbiome, reducing gas production, bloating, and associated pain in crying babies.
This solution gives colic babies a much happier start to life and improves the wellbeing of their caregivers.